Inhibrx Biosciences, Inc.INBXNASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
6.87%
↓ 80% below average
Average (8y)
34.36%
Historical baseline
Range
High:73.02%
Low:-2.80%
Volatility
220.7%
High variability
| Period | Value |
|---|---|
| 2024 | 6.87% |
| 2023 | 73.02% |
| 2022 | 54.24% |
| 2021 | -2.80% |
| 2020 | 53.41% |
| 2019 | 43.20% |
| 2018 | 31.14% |
| 2017 | 50.13% |
| 2016 | 0.00% |